| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04fb02190dac07816f88ecd6aa997e95 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4082 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d43b7f99a03f90ba4fb749044e4333bd |
| publicationDate |
2012-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2392862-A1 |
| titleOfInvention |
TGF-BETA AND / OR SMAD3 AS MARKERS OF DIAGNOSIS AND / OR FORECAST OF ALPHA-SINUCLEINOPATHIES |
| abstract |
TGF {be} and / or Smad3 as diagnostic and / or prognostic markers of {al} -synucleinopathies. # The present invention relates to a method for the diagnosis and / or prognosis of {al} -synucleinopathies in a sample obtained from a patient comprising determining the level of expression of the TGF {be} and / or Smad3 gene and / or the activity of the protein encoded by said gene and comparing said level with a control value, where the alteration of said level is indicative of { al} -synucleinopathy. |
| priorityDate |
2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |